Tech Company Financing Transactions
Humacyte Funding Round
On 6/13/2018, Humacyte landed $150 million in investment from Fresenius Medical Care.
Transaction Overview
Company Name
Announced On
6/13/2018
Transaction Type
Venture Equity
Amount
$150,000,000
Round
Undisclosed
Investors
Fresenius Medical Care (Franklin Maddux)
Proceeds Purpose
With the investment, Fresenius Medical Care will have the opportunity to bring transformative clinical innovation in the form of Humacyte's bioengineered human acellular vessels to the worldwide end stage renal disease (ESRD) patient population following product approval.
Company Information
Company Status
Private & Independent
Industry
Medical Devices & Instruments
Mailing Address
2525 E NC Hwy. 54
Durham, NC 27713
USA
Durham, NC 27713
USA
Phone
Website
Email Address
Overview
Humacyte uses proprietary technology to grow stable, off-the-shelf human tissue replacements such as vein grafts to pre-designed clinical and commercial specifications.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chairman
Carrie Cox
Chief Executive Officer
Jeffrey Lawson
Founder
Laura Niklason
VP - Bus. Development
Juliana Blum
VP - Regulatory Affairs
William Tente
Browse more venture capital transactions:
Prev: 6/13/2018: Vergent Bioscience venture capital transaction
Next: 6/14/2018: Tropic Biosciences venture capital transaction
Share this article
Where The Data Comes From
We do our best to record every notable VC transaction. VC investment data records reported here are sourced from news reports and company announcements. The data is sourced from VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs